We are looking for children 2–17 years of age to join a Crohn’s disease study to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or Inflammatory bowel disease (including associated symptoms such as stomach pain, abdominal cramps, constant need to poop, frequent fevers and/or anemia), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing moderate to severe UC flare-ups? Local UC clinical research study is testing a potential new medication to see if it may reduce cramping, unexplained weight loss, abdominal pain, weight loss, and/or canker sores associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the UC clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for children 2–17 years of age to join a Crohn’s disease (CD) research to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or moderate to severe IBD (including associated symptoms such as recurrent diarrhea, kidney stones, constant need to poop, malnutrition and/or eye pain), consider one of our CD studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the CD studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing moderately to severely active IBD flare-ups? Local CD research is testing a potential new medication to see if it may reduce rectal bleeding, mouth sores, constant need to poop, frequent fevers, and/or canker sores associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the CD research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

Is your child currently experiencing inflammatory bowel disease flare-ups? Local Crohn’s disease trial is testing a potential new medication to see if it may reduce stomach pain, weight loss, constant need to poop, weight loss, and/or anemia associated with inflammatory bowel disease.
If you’re concerned about how inflammatory bowel disease affects your child’s life, find out more about the Crohn’s disease trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for 2–17 years of age to join a Crohn’s disease clinical research study to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or UC (including associated symptoms such as cramping, iron deficiency, constant need to poop, weight loss and/or anemia), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

We are looking for 2 to 17 years old to join a CD medical research study to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or Crohn’s disease (CD) (including associated symptoms such as long-term diarrhea, perianal fistula, abdominal pain, chronic fatigue and/or canker sores), consider one of our clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

We are looking for children aged 2 to 17 years to join a CD clinical research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or ulcerative colitis (including associated symptoms such as urgency to defecate, persistent diarrhea, abdominal pain, chronic fatigue and/or canker sores), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

We are looking for children 2–17 years old to join a Crohn’s disease trial to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or moderate to severe UC (including associated symptoms such as rectal pain, blood in the stool, constant need to poop, malnutrition and/or joint pain), consider one of our GI clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the GI clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing ulcerative colitis flare-ups? Local Crohn’s disease clinical research study is testing a potential new medication to see if it may reduce fatigue, inflammation of the bowel or intestine, cramps, weight loss, and/or anemia associated with ulcerative colitis.
If you’re concerned about how ulcerative colitis affects your child’s life, find out more about the Crohn’s disease clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.